Online tool aims to empower myeloma patients
NCT ID NCT05673083
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a health technology platform called All4Cure can help people with multiple myeloma become more active in managing their own health. Two hundred participants will fill out surveys about their symptoms and how confident they feel in handling their care. No drugs or treatments are being tested—the goal is simply to see if the tool boosts patient engagement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that a simple online tool helps people with multiple myeloma become more involved in their own care, potentially improving their quality of life.
What could go wrong
This is a small pilot study with no drug or treatment being tested. It only measures patient engagement, not disease outcomes, so it may not lead to any direct health improvements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32003, United States
-
Hematology-Oncology Associates of Central New York
East Syracuse, New York, 13057, United States
-
Highlands Oncology Group
Fayetteville, Arkansas, 72703, United States
-
Misson Cancer + Blood
Des Moines, Iowa, 50314, United States
-
Northwest Medical Specialties PLLC
Tacoma, Washington, 98405, United States
-
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma, 74146, United States
-
Oncology Consultants
Houston, Texas, 77030, United States